BDBM163053 US9062004, 17::US9670216, 17 4-Chloro-5-dimethylamino-2-(3,5-dimethylphenyl)-pyridazin-3-one

SMILES CN(C)c1cnn(-c2cc(C)cc(C)c2)c(=O)c1Cl

InChI Key InChIKey=MCFOOTGYWAZLFW-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 163053   

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM163053(US9062004, 17 | US9670216, 17 4-Chloro-5-dimethyla...)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM163053(US9062004, 17 | US9670216, 17 4-Chloro-5-dimethyla...)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/7/2018
Entry Details
Go to US Patent